Key result
Systematic screening for depression in patients with CHD or diabetes increased new depression diagnoses in the following 4 weeks (Relative Incidence 3.03; 95% CI 2.44-3.78; number needed to screen 976).
Why the study?
Does routine screening for depression increase the incidence of new depression diagnosis or treatment in patients with coronary heart disease or diabetes?
Cohort (n=67,358)
Yes
Does routine screening for depression increase the incidence of new depression diagnosis or treatment in patients with coronary heart disease or diabetes?
Relative Risk: 3.03 (95% CI 2.44–3.78)
Number Needed to Treat: 976
Systematic screening for depression in primary care patients with CHD or diabetes leads to a small but significant increase in new depression diagnoses and treatments within 4 weeks.
No takes yet. Share an insight, caveat, or question.
Screening may increase short-term diagnoses; leaves open whether routine use improves outcomes or warrants adoption in CHD or diabetes.
Burton et al. (2012) conducted a cohort in Coronary heart disease (CHD) or diabetes (n=67,358). Annual screening for depression vs. Other times (outside the 1-28 days post-screening period) was evaluated on New diagnosis of depression in the period 1-28 days after screening (RI 3.03, 95% CI 2.44-3.78). Systematic screening for depression in patients with CHD or diabetes increased new depression diagnoses in the following 4 weeks (Relative Incidence 3.03; 95% CI 2.44-3.78; number needed to screen 976).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: